DK3041576T3 - Fremgangsmåder til at detektere nyresygdom - Google Patents

Fremgangsmåder til at detektere nyresygdom Download PDF

Info

Publication number
DK3041576T3
DK3041576T3 DK14842603.4T DK14842603T DK3041576T3 DK 3041576 T3 DK3041576 T3 DK 3041576T3 DK 14842603 T DK14842603 T DK 14842603T DK 3041576 T3 DK3041576 T3 DK 3041576T3
Authority
DK
Denmark
Prior art keywords
methods
kidney disease
detecting kidney
detecting
disease
Prior art date
Application number
DK14842603.4T
Other languages
English (en)
Inventor
Mahalakshmi Yerramilli
Murthy V S N Yerramilli
Original Assignee
Idexx Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52628954&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3041576(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idexx Lab Inc filed Critical Idexx Lab Inc
Application granted granted Critical
Publication of DK3041576T3 publication Critical patent/DK3041576T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806Determination of free amino acids
    • G01N33/6812Assays for specific amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK14842603.4T 2013-09-05 2014-09-05 Fremgangsmåder til at detektere nyresygdom DK3041576T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361874011P 2013-09-05 2013-09-05
PCT/US2014/054278 WO2015035155A1 (en) 2013-09-05 2014-09-05 Methods for detecting renal disease

Publications (1)

Publication Number Publication Date
DK3041576T3 true DK3041576T3 (da) 2019-09-09

Family

ID=52628954

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14842603.4T DK3041576T3 (da) 2013-09-05 2014-09-05 Fremgangsmåder til at detektere nyresygdom

Country Status (21)

Country Link
US (3) US11035861B2 (da)
EP (3) EP4295907A3 (da)
JP (4) JP6657096B2 (da)
KR (2) KR102412431B1 (da)
CN (1) CN105705202B (da)
AU (2) AU2014315063B2 (da)
CA (2) CA2923140C (da)
CY (1) CY1123179T1 (da)
DK (1) DK3041576T3 (da)
ES (2) ES2746008T3 (da)
HR (1) HRP20191569T1 (da)
HU (1) HUE045723T2 (da)
LT (1) LT3041576T (da)
MX (2) MX383274B (da)
NZ (1) NZ717554A (da)
PL (1) PL3041576T3 (da)
PT (1) PT3041576T (da)
RS (1) RS59287B1 (da)
SI (1) SI3041576T1 (da)
SM (1) SMT201900526T1 (da)
WO (1) WO2015035155A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE045723T2 (hu) 2013-09-05 2020-01-28 Idexx Lab Inc Módszerek vesebetegség kimutatására
US10775365B2 (en) 2015-02-20 2020-09-15 Idexx Laboratories, Inc. Homogenous immunoassay with compensation for background signal
ES3041077T3 (en) * 2015-04-30 2025-11-07 Idexx Lab Inc Methods for detecting renal disease
US11771113B2 (en) 2017-05-31 2023-10-03 Mars, Incorporated Methods of diagnosing and treating chronic kidney disease
US11026625B2 (en) 2017-08-08 2021-06-08 Fresenius Medical Care Holdings, Inc. Systems and methods for treating and estimating progression of chronic kidney disease
AU2018351349B2 (en) * 2017-10-19 2025-08-14 Idexx Laboratories, Inc. Detection of symmetrical dimethylarginine
WO2020080484A1 (ja) * 2018-10-17 2020-04-23 株式会社 資生堂 糸球体濾過能力の決定方法
CN109545377B (zh) * 2018-10-22 2021-11-23 中南大学湘雅三医院 获取肾小球滤过率的模型的建立方法
US10745492B1 (en) * 2019-04-03 2020-08-18 Ark Diagnostics, Inc. Antibodies to symmetrically dimethylated arginine analytes and use thereof
WO2021046339A1 (en) 2019-09-05 2021-03-11 The Regents Of The University Of California Noninvasive method to quantify kidney function and functional decline
WO2021132658A1 (ja) * 2019-12-27 2021-07-01 Kagami株式会社 腎機能を推定する方法及びシステム
GB202005110D0 (en) * 2020-04-07 2020-05-20 Royal Veterinary College Diagnosis of stage b2 dmvd
JP7784798B2 (ja) * 2020-04-17 2025-12-12 株式会社藤商事 遊技機
EP4263383A4 (en) 2020-12-17 2024-10-23 Nephrosant, Inc. KITS FOR STABILIZATION OF URINE SAMPLES
CN112768073B (zh) * 2021-01-15 2023-04-18 中山大学附属第三医院 一种肾小球滤过率估计模型的构建方法
JP2023160475A (ja) * 2022-04-22 2023-11-02 株式会社三共 遊技機
KR102880012B1 (ko) * 2023-12-22 2025-11-10 주식회사 페토바이오 반려동물의 신부전 치료를 위한 임상 의사결정 지원 시스템 및 임상 의사결정 지원 방법
CN119125582A (zh) * 2024-09-20 2024-12-13 武汉虹之彩包装印刷有限公司 一种用于肌酐检测的纸基传感器及其制备方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134787A1 (de) 1981-09-02 1983-03-10 Boehringer Mannheim Gmbh, 6800 Mannheim Creatinin-antikoerper
US4818703A (en) 1985-10-23 1989-04-04 Pizzolante John M Stabilized alkaline picrate reagent for jaffe creatinine determination
EP0356160A3 (en) 1988-08-24 1991-09-11 The Board Of Trustees Of The Leland Stanford Junior University Capillary device
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US6455288B1 (en) 1993-04-08 2002-09-24 Dade Behring Marburg Gmbh Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
US5804452A (en) * 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
WO1998049199A1 (en) 1997-05-01 1998-11-05 Panorama Research, Inc. Cardiovascular disease risk assessment
US6736957B1 (en) 1997-10-16 2004-05-18 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors and process for using
US6358699B1 (en) 1999-02-05 2002-03-19 Cooke Pharma Assay for asymmetrical NG, NG dimethyl-l-arginine
US6699673B2 (en) 1999-12-22 2004-03-02 The Research Foundation Of State University Of New York Protein methylarginine-specific antibodies
JP2004502948A (ja) 2000-07-06 2004-01-29 ファル ダイアグノスティクス アルギニン化合物の検出のための方法及びキット
DE60133558D1 (de) * 2000-07-12 2008-05-21 Werner Naser Direkte bestimmung des quotients von analyt- zu referenzmolekülen
DE10040904A1 (de) 2000-08-18 2002-02-28 Boeger Rainer H Verfahren und Mittel zum Nachweis einer Wahrscheinlichkeit zukünftigen Fortschreitens von Gefässerkrankungen
US7241856B2 (en) 2003-06-02 2007-07-10 Pentron Clinical Technologies Llc Dental resins, dental composite materials, and method of manufacture thereof
JP4214271B2 (ja) 2002-10-15 2009-01-28 アークレイ株式会社 クレアチニン測定用試験片
US7501053B2 (en) 2002-10-23 2009-03-10 Abbott Laboratories Biosensor having improved hematocrit and oxygen biases
AU2003290784A1 (en) 2002-11-15 2004-06-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for detecting asymmetric dimethylarginine in a biological sample
US20050148029A1 (en) 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
EP1666884B1 (en) 2004-11-04 2009-04-01 GermedIQ Forschungs- und Entwicklungsgesellschaft mbH Method for determination of arginine, methylated arginines and derivatives thereof
US8424012B1 (en) 2004-11-15 2013-04-16 Nvidia Corporation Context switching on a video processor having a scalar execution unit and a vector execution unit
WO2006078813A2 (en) 2005-01-21 2006-07-27 Biosite Incorporated Arginine analogs, and methods for their synthesis and use
JP2007176872A (ja) 2005-12-28 2007-07-12 Sentan Seimei Kagaku Kenkyusho:Kk アシンメトリックジメチルアルギニンを認識する抗体及びその製造方法並びに翻訳後修飾アミノ酸含有タンパク質の検出方法
FR2919063B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
JP5385914B2 (ja) * 2007-12-05 2014-01-08 キングス カレッジ ロンドン 方法及び組成物
PL2313364T3 (pl) * 2008-08-07 2021-03-08 Idexx Laboratories, Inc. Sposoby wykrywania symetrycznej dimetyloargininy
CA2763948C (en) * 2009-06-02 2019-03-12 Biocrates Life Sciences Ag Combination of amino acids, acylcarnitines and biogenic amines for the assessment of chronic kidney disease
CN101587118B (zh) * 2009-07-03 2012-09-12 长春迪瑞医疗科技股份有限公司 肌酐尿液分析试纸及制备方法
CN101598727B (zh) * 2009-07-09 2012-10-10 上海科华生物工程股份有限公司 定量测定人体血液尿素含量的干化学试纸
US9285246B2 (en) * 2010-02-12 2016-03-15 Intuitive Surgical Operations, Inc. Method and system for absolute three-dimensional measurements using a twist-insensitive shape sensor
CN101865911A (zh) * 2010-03-16 2010-10-20 苏州市玮琪生物科技有限公司 一种尿肌酐定量检测卡
EP2612147B1 (de) 2010-11-17 2016-03-30 Karl-Heinz Kellner Automatenfähiger immunoassay für biogene amine
JP2012112785A (ja) 2010-11-24 2012-06-14 Tohoku Univ 透析膜の評価方法
JP5925026B2 (ja) * 2011-04-28 2016-05-25 アークレイ株式会社 クレアチニン測定用乾式試験片及びクレアチニン測定法
AU2012271718A1 (en) * 2011-06-16 2014-01-09 Baylor Research Institute Analysis of total homocysteine and methylmalonic acid in plasma by LC-MS/MS from a plasma separator device (PSD)
JP2013178239A (ja) * 2012-01-31 2013-09-09 Ajinomoto Co Inc 早期腎症の評価方法、早期腎症評価装置、早期腎症評価方法、早期腎症評価プログラム、早期腎症評価システムおよび情報通信端末装置
US20140038203A1 (en) * 2012-07-09 2014-02-06 Musc Foundation For Research Development Methods for detecting or predicting kidney disease
HUE045723T2 (hu) 2013-09-05 2020-01-28 Idexx Lab Inc Módszerek vesebetegség kimutatására

Also Published As

Publication number Publication date
NZ717554A (en) 2022-04-29
SMT201900526T1 (it) 2019-11-13
US20250271442A1 (en) 2025-08-28
SI3041576T1 (sl) 2019-11-29
AU2020256440A1 (en) 2020-11-12
CN105705202A (zh) 2016-06-22
HRP20191569T1 (hr) 2019-11-29
JP2024020376A (ja) 2024-02-14
AU2014315063A1 (en) 2016-03-17
ES2969979T3 (es) 2024-05-23
EP3480600C0 (en) 2023-11-08
MX2016002922A (es) 2016-11-07
JP2022070879A (ja) 2022-05-13
EP3041576B1 (en) 2019-06-19
LT3041576T (lt) 2019-10-25
KR20210082567A (ko) 2021-07-05
AU2020256440B2 (en) 2023-03-02
PL3041576T3 (pl) 2019-12-31
PT3041576T (pt) 2019-09-27
KR102412431B1 (ko) 2022-06-22
CA2923140A1 (en) 2015-03-12
MX383274B (es) 2025-03-13
EP4295907A2 (en) 2023-12-27
KR102273028B1 (ko) 2021-07-02
EP3480600A1 (en) 2019-05-08
CA2923140C (en) 2023-09-26
CY1123179T1 (el) 2021-10-29
AU2014315063B2 (en) 2020-07-23
US11035861B2 (en) 2021-06-15
JP2020073927A (ja) 2020-05-14
EP3480600B1 (en) 2023-11-08
EP3041576A4 (en) 2017-07-26
WO2015035155A1 (en) 2015-03-12
JP6657096B2 (ja) 2020-03-04
KR20160051887A (ko) 2016-05-11
JP2016530532A (ja) 2016-09-29
CN105705202B (zh) 2019-02-26
US20160187348A1 (en) 2016-06-30
EP4295907A3 (en) 2024-03-13
MX2021006716A (es) 2021-07-15
CA3213810A1 (en) 2015-03-12
ES2746008T3 (es) 2020-03-04
BR112016004839A8 (pt) 2020-02-11
RS59287B1 (sr) 2019-10-31
EP3041576A1 (en) 2016-07-13
HUE045723T2 (hu) 2020-01-28
US20220137059A1 (en) 2022-05-05

Similar Documents

Publication Publication Date Title
IL285521A (en) Assays for single molecule detection
IL281485B (en) Tracked all-terrain vehicle
DK3041576T3 (da) Fremgangsmåder til at detektere nyresygdom
DK2972351T3 (da) Forbedrede analysemetoder
IL246002A0 (en) Novel methods
DK2996556T3 (da) System til billedstyret procedure
LT3074534T (lt) Būdai, skirti polinukleotido sekoskaitai
IL243311A0 (en) Novel antibody frameworks
DK3030323T3 (da) Kdm1a-inhibitorer til behandlingen af sygdom
DK3736291T5 (da) Anti-FCRH5-antistoffer
DK2881868T3 (da) Søgegrænseflade
EP3083682C0 (en) DOUBLE SPECIFICITY ANTIBODIES
LT3060041T (lt) Prostaciklino junginiai
DK3004155T3 (da) Peptidforbindelse
DK3708583T3 (da) Ikke-fucosylerede anti-fgfr2iiib-antistoffer
HRP20171851T1 (hr) Spojevi tetrahidropirolotiazina
DK2970389T3 (da) Farmaceutiske forbindelser
DK3076786T3 (da) Fælde
DK3041349T3 (da) Anordning til angrebsdiagnose
DK3068800T3 (da) FcRn-specifikke antistoffer
DK2969098T3 (da) Fremgangsmåder til oprensning af antistoffer
DK2971191T3 (da) Lactosegenvinding
DK3065774T3 (da) Anti-CCL17-antistoffer
IL240904A0 (en) Azetidinyloxyphenylpyrrolidine compounds
GB201317621D0 (en) Kidney disease biomarker